BackAditxt Overview

Aditxt Current Cash

Track Aditxt's current cash ($270K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$268852.00
↓ 43.57% YoYΔ $-207564.00 vs prior year quarter

Peer average

Loading

Aditxt Current Cash History

Loading

Aditxt vs. peers: Current Cash Comparison

Loading

Aditxt Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Aditxt (ADTX) FAQ

Aditxt (ADTX) currently reports a current cash of $270K as of March 2026. That compares with $480K in the prior-year period — down 43.6% year over year. Use the charts on this page to explore Aditxt's current cash history and peer comparisons.

Aditxt's current cash decreased from $480K to $270K — a 43.6% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aditxt reported $270K in current cash as of March 2026. That compares with $480K in the prior-year period — down 43.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $270K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aditxt, and consider following ADTX for alerts when major investors trade the stock.

Aditxt is classified in the Healthcare sector. On current cash, it currently shows $270K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ADTX with unrelated industries.